Development of cold-adapted recombinant live, attenuated influenza A vaccines in the U.S.A. and U.S.S.R.
- 28 February 1982
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 1 (6) , 339-365
- https://doi.org/10.1016/0166-3542(82)90034-1
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Genetics - Studies on mutation lesions and physiology of fowl plague virus ts mutantsPhilosophical Transactions of the Royal Society of London. B, Biological Sciences, 1980
- Analysis of virion RNA segments and polypeptides of influenza A virus recombinants of defined virulenceNature, 1978
- Interpandemic Influenza in the Houston Area, 1974–76New England Journal of Medicine, 1978
- Cold adapted variants of influenza AArchiv für die gesamte Virusforschung, 1977
- Pilot Studies on Recombinant Cold-Adapted Live Type A and B Influenza Virus VaccinesThe Journal of Infectious Diseases, 1977
- RNAs of influenza virus recombinants derived from parents of known virulence for manArchiv für die gesamte Virusforschung, 1977
- TRIALS IN MAN WITH LIVE RECOMBINANTS MADE FROM A/PR/8/34 (H0 N1) AND WILD H3 N2 INFLUENZA VIRUSESThe Lancet, 1975
- RECOMBINANT WRL 105 STRAIN LIVE ATTENUATED INFLUENZA VACCINE: Immunogenicity, Reactivity, and TransmissibilityThe Lancet, 1975
- RECOMBINANT INFLUENZA-A VIRUSES AS LIVE VACCINES FOR MAN: Report to the Medical Research Council's Committee on Influenza and other Respiratory Virus VaccinesThe Lancet, 1971
- Virulence of Temperature-sensitive Mutants of Influenza VirusBMJ, 1969